We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Updated Phase III Data Confirm Overall Survival Benefit of Alpharadin in Men with CRPC

News   Jun 04, 2012

 
Updated Phase III Data Confirm Overall Survival Benefit of Alpharadin in Men with CRPC
 
 
 

RELATED ARTICLES

First-degree Relatives of Blood Cancer Patients at Greater Risk

News

Those with a parent, sibling or child affected by blood cancer are more likely to be diagnosed with the disease, according to a new study.

READ MORE

New Method to Synthesize and Screen Macrocyclic Compounds

News

Scientists at EPFL have found a way to generate libraries of more than 9,000 of macrocyclic molecules below 1 KDa, all with high structural diversity.

READ MORE

Converting Macrophages Into Cancer Killers

News

Scientists have identified a new therapeutic approach in mouse models that halts drug resistance and progression by using a monoclonal antibody that induces the immune system to seek and kill ανβ3-expressing cancer cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE